> High Tech Business Decisions says it expects the market for single-use systems to grow at double-digit rates, with similar growth rates for disposables supporting both upstream and downstream bioprocesses. Article (sub. req.)
> European contract manufacturer Fareva plans to continue operating the factory in Henrico, VA, it's buying from Pfizer ($PFE) and invest $42 million. Story
> Twin-screw extrusion, a process common in the plastics industry, is being studied at Bradford University for use in making co-crystals, which offer an alternative means of creating targeted soluble drug compounds. Story
> GLP- and GMP-compliant contract lab Advantar, which provides analytical and formulation development services, has entered a non-exclusive strategic alliance with DavosPharma, provider of chemistry and pharma development management solutions. Item
> Big 3 Distributor AmerisourceBergen ($ABC) has acquired Premier Source, a reimbursement consultancy to medical device, pharma, molecular diagnostic and biotechnology manufacturers. AmericasourceBergen release
> Generic drugmakers must ensure their products follow the same scoring practices as references drugs. Draft guidance
> Pfizer says it has signed a 10-year lease with the Massachusetts Institute of Technology (MIT) for more than 180,000 square feet in a new building under development in Cambridge, MA, for cardiovascular R&D. Story